<DOC>
	<DOCNO>NCT02034734</DOCNO>
	<brief_summary>The purpose study evaluate plasma cerebrospinal fluid ( CSF ) pharmacokinetics ( PK ) multiple dos ASP3652 healthy young Caucasian male subject . Also evaluate plasma CSF pharmacodynamics ( PD ) multiple dos ASP3652 healthy young Caucasian male subject assess safety tolerability multiple dos ASP3652 healthy young Caucasian male subject .</brief_summary>
	<brief_title>A Study Investigate Appearance Disappearance ASP3652 Blood Spinal Fluid Healthy Male Subjects</brief_title>
	<detailed_description>Screening take place Day -22 Day -2 . Subjects admit clinical Day -1 remain Day 12 . On Days 5 9 , subject receive twice-daily dos ASP3652 , single dose morning Day 10 . Subjects fast 10h morning dose Days 5 9 serve first standard meal 1h morning dose . A spinal tap use collect cerebrospinal fluid ( CSF ) Day 1 Day 10 . A plasma sample PK sample obtain first dose Day 5 . To confirm steady-state concentration ASP3652 plasma , blood sample obtain morning dose Days 7 , 9 10 , even dose Days 5 , 7 9 . On Day 10 , PK profile ASP3652 plasma obtain 48h morning dose 24h CSF . Profiles several enzyme substrate plasma seminal fluid ( exploratory ) obtain Day 1 Day 10 24h CSF 48h plasma , morning even dose Days 5 , 7 9 plasma . Vital sign , 12-lead electrocardiogram ( ECGs ) , safety laboratory assessment , adverse event ( AEs ) concomitant medication monitor throughout investigational period ESV .</detailed_description>
	<criteria>Subject white Caucasian origin . Body Mass Index equal 18.5 less 30.0 kg/m2 . Male subject must agree practice adequate contraceptive method female sexual partner prevent pregnancy . Known suspected hypersensitivity ASP3652 component formulation use . History excessive bleeding bruising . Abnormalities coagulation screen include platelet count , prothrombin time ( PT ) activate partial thromboplastin time ( aPTT ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>ASP3652</keyword>
	<keyword>Cerebrospinal fluid ( CSF )</keyword>
	<keyword>Multiple dos</keyword>
</DOC>